Detection of CD8+ T cell responses to M. tuberculosis
AssigneeIsis Innovation Limited
InventorsAjit Lalvani, Ansar A. Pathan
Life of this patent
Estimating the term…
Loading patent…
AssigneeIsis Innovation Limited
InventorsAjit Lalvani, Ansar A. Pathan
Estimating the term…
A method of detecting an anti-mycobacterial CD8 T cell response comprising contacting a population of CD8 T cells of an individual with one or more peptides selected from the peptides represented by SEQ ID NO: 3, 4, 7, 8, 9, 10, 11 or 12, and, optionally, one or two further peptides represented by SEQ ID NO: 1 and/or 2, wherein one or more of said peptides may be substituted by an analogue which binds a T cell receptor which recognises the corresponding substituted peptide, and determining whether CD8 T cells of the CD8 T cell population recognize the peptide(s). The invention also provides a method of vaccinating against infection by a mycobacterium, wherein the vaccination leads to a CD8 T cell response, comprising administering (i) a CD8 T cell epitope of a mycobacterium protein, (ii) an analogue of the epitope which is capable of inhibiting the binding of the epitope to a T cell receptor, (iii) a precursor or (i) or (ii) which is capable of being processed to provide (i) or (ii), or (iv) a polynucleotide which is capable of being expressed to provide (i), (ii) or (iii).
A method of detecting an anti-mycobacterial CD8 T cell response comprising contacting a population of CD8 T cells of a human individual with one or more peptides selected from the group consisting of SEQ ID NOS:3, 4, 7, 8, 9, 10, 11 and 12, and, optionally, one or two further peptides selected from the group consisting of SEQ ID NOS:1 and 2, wherein one or more peptides may be substituted by an analogue which binds a T cell receptor that recognizes the peptide, and determining whether CD8 T cells of the CD8 T cell population recognize the peptide(s).
A kit comprising one or more peptides selected from the group consisting of SEQ ID NOS:3, 8, 9, 10, 11 and 12, and, optionally, one or two further peptides selected from the group consisting of SEQ ID NOS:1 and 2, wherein one or more peptides may be substituted by an analogue which binds a T cell receptor which recognizes the peptide, and optionally a means to detect recognition of the peptide(s) by CD8 T cells.
A kit comprising a peptide panel, wherein said panel includes peptides consisting of SEQ ID NOS:1, 2, 3, 4, 8, 9 and 10, wherein one or more peptides may be substituted by an analogue which binds a T cell receptor which recognizes the peptide.
Dependencies are inferred from the claim text.